10-114843032-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_020940.4(FHIP2A):c.622C>T(p.Arg208Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_020940.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHIP2A | NM_020940.4 | c.622C>T | p.Arg208Cys | missense_variant | 6/17 | ENST00000369248.9 | NP_065991.3 | |
FHIP2A | NM_001135051.2 | c.622C>T | p.Arg208Cys | missense_variant | 6/17 | NP_001128523.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHIP2A | ENST00000369248.9 | c.622C>T | p.Arg208Cys | missense_variant | 6/17 | 1 | NM_020940.4 | ENSP00000358251.4 | ||
FHIP2A | ENST00000369250.7 | c.622C>T | p.Arg208Cys | missense_variant | 6/17 | 1 | ENSP00000358253.3 | |||
FHIP2A | ENST00000710382.1 | c.718C>T | p.Arg240Cys | missense_variant | 6/17 | ENSP00000518239.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251132Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135720
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461654Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727150
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74280
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at